UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression

Cell death & disease, 2019-01, Vol.10 (2), p.37-37, Article 37

2019

Volltextzugriff (PDF)

Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Frontiers in oncology, 2021-05, Vol.11, p.666418-666418

2021

Volltextzugriff (PDF)

MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer

Journal of experimental & clinical cancer research, 2015-01, Vol.34 (1), p.8-8, Article 8

2015

Volltextzugriff (PDF)

Single-cell transcriptome atlas of the human corpus cavernosum

Nature communications, 2022-07, Vol.13 (1), p.4302-4302, Article 4302

2022

Volltextzugriff (PDF)

Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death

Cell death & disease, 2021-01, Vol.12 (1), p.68-68, Article 68

2021

Volltextzugriff (PDF)

CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5p

Open medicine (Warsaw, Poland), 2019-01, Vol.14 (1), p.833-842

2019

Volltextzugriff (PDF)

Functional Silencing of HSD17B2 in Prostate Cancer Promotes Disease Progression

Clinical cancer research, 2019-02, Vol.25 (4), p.1291-1301

2019

Volltextzugriff (PDF)

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Frontiers in oncology, 2021-07, Vol.11, p.731942-731942

2021

Volltextzugriff (PDF)

CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer

European journal of medical research, 2022-07, Vol.27 (1), p.1-105, Article 105

2022

Volltextzugriff (PDF)

Prostate cancer identification via photoacoustic spectroscopy and machine learning

Photoacoustics (Munich), 2021-09, Vol.23, p.100280-100280, Article 100280

2021

Volltextzugriff (PDF)

A Novel Androgen-Induced lncRNA FAM83H-AS1 Promotes Prostate Cancer Progression via the miR-15a/CCNE2 Axis

Frontiers in oncology, 2021-02, Vol.10, p.620306-620306

2021

Volltextzugriff (PDF)

Study on clinical outcomes between non-transecting urethroplasty and lingual mucosal urethroplasty for iatrogenic bulbar urethral stricture treatment

Basic and clinical andrology, 2023-05, Vol.33 (1), p.12-12, Article 12

2023

Volltextzugriff (PDF)

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling

Cell death & disease, 2024-02, Vol.15 (2), p.128-128, Article 128

2024

Volltextzugriff (PDF)

High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling

Cell death discovery, 2022-03, Vol.8 (1), p.128-128, Article 128

2022

Volltextzugriff (PDF)

Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis

Frontiers in oncology, 2021-06, Vol.11, p.650054-650054

2021

Volltextzugriff (PDF)

Quick identification of prostate cancer by wavelet transform-based photoacoustic power spectrum analysis

Photoacoustics (Munich), 2022-03, Vol.25, p.100327-100327, Article 100327

2022

Volltextzugriff (PDF)

Identification of cuproptosis-related genes for predicting the development of prostate cancer

Open medicine (Warsaw, Poland), 2023-09, Vol.18 (1), p.20230717-33

2023

Volltextzugriff (PDF)

Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide

Clinical and translational medicine, 2021-07, Vol.11 (7), p.e495-n/a

2021

Volltextzugriff (PDF)

Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis

Discover. Oncology, 2022-06, Vol.13 (1), p.54-54, Article 54

2022

Volltextzugriff (PDF)

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression

Cell death discovery, 2023-10, Vol.9 (1), p.392-392, Article 392

2023

Volltextzugriff (PDF)

Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer

Technology in cancer research & treatment, 2021, Vol.20, p.15330338211052154-15330338211052154

2021

Volltextzugriff (PDF)

PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7

Frontiers in cell and developmental biology, 2021-12, Vol.9, p.783050-783050

2021

Volltextzugriff (PDF)

Identification of an immune‐related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma

Immunity, Inflammation and Disease, 2022-09, Vol.10 (9), p.e680-n/a

2022

Volltextzugriff (PDF)

Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy

Urologic oncology, 2013-11, Vol.31 (8), p.1539-1545

2013

Volltextzugriff (PDF)

Preliminary clinical study on non-transecting anastomotic bulbomembranous urethroplasty

Frontiers of medicine, 2017-06, Vol.11 (2), p.277-283

2017

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression

Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer

Single-cell transcriptome atlas of the human corpus cavernosum

Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death

CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5p

Functional Silencing of HSD17B2 in Prostate Cancer Promotes Disease Progression

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer

Prostate cancer identification via photoacoustic spectroscopy and machine learning

A Novel Androgen-Induced lncRNA FAM83H-AS1 Promotes Prostate Cancer Progression via the miR-15a/CCNE2 Axis

Study on clinical outcomes between non-transecting urethroplasty and lingual mucosal urethroplasty for iatrogenic bulbar urethral stricture treatment

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling

High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling

Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis

Quick identification of prostate cancer by wavelet transform-based photoacoustic power spectrum analysis

Identification of cuproptosis-related genes for predicting the development of prostate cancer

Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide

Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression

Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer

PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7

Identification of an immune‐related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma

Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy

Preliminary clinical study on non-transecting anastomotic bulbomembranous urethroplasty

Suchergebnisse filtern